Cellectis S.A.

NASDAQ: CLLS · Real-Time Price · USD
2.85
-0.01 (-0.35%)
At close: Aug 15, 2025, 3:59 PM
2.85
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT

Cellectis S.A. Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
16.94M 10.65M 12.72M 16.2M 8.06M 4.53M 283K 155K 178K 139K 16.02M 217K 1.35M 1.7M 13.65M 8.31M 11.18M 25.6M
Cost of Revenue
n/a 2.02M 2.52M 4.72M 4.73M 4.57M 5.34M 181K 55K 334K 690K 367K 329K 385K 18.64M 9.21M 11.76M 8.14M
Gross Profit
11.86M 8.64M 10.2M 11.48M 3.33M -41K -5.06M -26K 123K -195K 15.33M -150K 1.02M 1.31M -5M -902K -579K 17.46M
Operating Income
-11.58M -14.18M -10.68M -12.8M -23.99M -22.9M -30.75M -20.67M -23.66M -23.43M -5.66M -33.16M -34.08M -35.25M -39.16M -42.37M -37.48M -19.91M
Interest Income
2.22M 2.91M 3.57M 3.02M 2.77M 1.92M 1.45M 723K 32.27M 775K 489K 364K 205K 2.27M 1.72M 2.3M 103K 5.7M
Pretax Income
-25.56M -18.13M 6.44M -24.93M -26.87M 3.45M -64.36M -17.38M -7.68M -27.83M -25.61M -31.27M -19.45M -34.76M -46.73M -40.07M -41.61M -15.34M
Net Income
-24.04M -18.13M 5.92M -23.06M -25.27M 5.64M -42.86M -17.48M -10.65M -30.07M -25.7M -24.68M -18.95M -31.91M -40.61M -37.41M -39.92M -11.87M
Selling & General & Admin
5.14M 2.33M 3.45M 447K 3.8M 535K 161K 1.56M 3.95M 2.82M 1.7M 7.64M 8.42M 9.28M 12.49M 9.68M 9.34M 8.78M
Research & Development
18.66M 21.93M 20.87M 23.83M 23.52M 22.32M 25.53M 18.89M 22.14M 21.08M 21.43M 26.67M 29.05M 29.48M 23.39M 34.32M 31.15M 31M
Other Expenses
n/a -1.45M -918K n/a n/a n/a n/a n/a n/a -667K -2.14M -1.3M n/a n/a 7.94M n/a n/a n/a
Operating Expenses
28.51M 22.82M 23.4M 24.28M 27.32M 22.86M 25.69M 20.64M 23.78M 23.24M 20.99M 33.01M 35.1M 36.56M 34.17M 41.47M 36.9M 37.36M
Interest Expense
n/a 1.91M 1.72M 2.15M 1.83M 1.79M 1.55M 1.51M 16.28M 5.18M n/a 928K 974K 1.36M 8.61M n/a 4.23M 1.14M
Selling & Marketing Expenses
n/a n/a n/a -4.72M -78.5K -4.57M -4.51M n/a 1.28M 728K -16M 1.31M n/a n/a 2.51M n/a n/a n/a
Cost & Expenses
28.51M 24.83M 25.84M 29M 32.05M 27.43M 31.03M 20.83M 23.84M 23.57M 21.68M 33.38M 35.42M 36.95M 52.81M 50.68M 48.66M 45.51M
Income Tax Expense
-1.52M 1K 514K -1.88M -1.6M -2.19M -740K 106K 258K 2.24M 87K -6.59M -507K 129K -11.16M -2.66M -1.69M 2.22M
Shares Outstanding (Basic)
100.33M 100.16M 100.09M 100.09M 90.25M 71.81M 71.75M 55.58M 55.58M 51.45M 45.65M 45.19M 45.11M 45.49M 45.48M 45.47M 45.46M 42.39M
Shares Outstanding (Diluted)
100.33M 100.16M 100.09M 100.09M 90.25M 103.09M 71.75M 55.58M 55.58M 51.45M 45.65M 45.54M 45.11M 45.49M 45.48M 45.47M 45.46M 42.87M
EPS (Basic)
-0.24 -0.18 0.06 -0.23 -0.28 0.08 -0.6 -0.31 -0.19 -0.58 -0.56 -0.55 -0.42 -0.7 -0.89 -0.82 -0.88 -0.28
EPS (Diluted)
-0.24 -0.18 0.06 -0.23 -0.28 0.05 -0.6 -0.31 -0.19 -0.58 -0.56 -0.54 -0.42 -0.7 -0.89 -0.82 -0.88 -0.28
EBITDA
-18.95M -11.29M 12.7M -18.07M -20.31M 9.81M -41.62M -12.73M -21.2M -21.32M -14.98M -23.36M -17.22M -26.66M -23.25M -37.17M -35.88M -12.81M
EBIT
-24.04M -16.22M 6.87M -22.79M -23.63M 7.17M -62.07M -15.87M -28.12M -25.77M -15.22M -24.62M -18.04M -26.96M -29.16M -41.54M -37.48M -14.21M
Depreciation & Amortization
5.08M 4.93M 5.83M 4.72M 4.73M 4.57M 5.18M 4.47M 4.42M 4.46M 2.97M 8.29M 1.56M 5.61M 5.03M 4.37M 3.41M 3.77M